Orion Infusion Limited (DSE: ORIONINFU)
Health Care · Pharmaceuticals · BD
Tk257.70
-1.98% today · -50.2% 1Y
Orion Infusion Limited (DSE: ORIONINFU) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $42.63M.
Over the last twelve months the share price has lost 50.2%, trading between 159.00 and 530.00.
Tweenvest scores Orion Infusion Limited across four factors: quality 67/100, value 51/100, growth 0/100, dividend 13/100. Its strongest factor is quality.
ORIONINFU price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $42.63M
- Revenue (TTM)
- $5.28M
- P/E
- 147.74
- EPS
- 1.74
- Dividend yield
- 0.78%
- Beta (5Y)
- -1.80
- 52-week high
- Tk530.00
- 52-week low
- Tk159.00
- Avg volume (3M)
- —
- Shares outstanding
- 20.36M
- Employees
- —
- Next earnings
- —
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Neurizon Therapeutics LimitedASX: NUZ | $43.10M | AU$0.08 | +3.90% |
| Sofgen Pharma S.A.OTCPK: PROC.F | $43.07M | $— | — |
| Veru Inc.NasdaqCM: VERU | $42.80M | $2.42 | -3.59% |
| Hayat Pharmaceutical Industries Co. PLCASE: HPIC | $42.77M | JD3.19 | +1.27% |
| Jenburkt Pharmaceuticals LimitedBSE: 524731 | $42.42M | Rs925.40 | -2.43% |
| Neurothera Labs Inc.TSXV: NTLX | $42.38M | CA$4.40 | +0.23% |
| Herantis Pharma OyjHLSE: HRTIS | $42.30M | €1.42 | +1.29% |
| ADBiotech Co., Ltd.KOSDAQ: A179530 | $41.12M | ₩2,055.00 | +17.16% |
Figures last refreshed Oct 4, 2026.